120747-86-6 Usage
General Description
2-Amino-5-chloromethylpyrimidine is a chemical compound with the molecular formula C5H6ClN3. It is a pyrimidine derivative with a chlorine atom and an amino group attached to the pyrimidine ring. 2-Amino-5-chloromethylpyrimidine is commonly used as a building block in the synthesis of pharmaceutical compounds and agrochemicals. It has been studied for its potential biological activities, including its use as an anti-cancer agent and for the treatment of parasitic infections. 2-Amino-5-chloromethylpyrimidine is a white to yellow solid with a melting point of around 184-186°C and is sparingly soluble in water. Its chemical structure and properties make it a versatile intermediate in the production of various organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 120747-86-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,7,4 and 7 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 120747-86:
(8*1)+(7*2)+(6*0)+(5*7)+(4*4)+(3*7)+(2*8)+(1*6)=116
116 % 10 = 6
So 120747-86-6 is a valid CAS Registry Number.
InChI:InChI=1/C5H6ClN3/c6-1-4-2-8-5(7)9-3-4/h2-3H,1H2,(H2,7,8,9)
120747-86-6Relevant articles and documents
OXABOROLE ESTERS AND USES THEREOF
-
Page/Page column 122, (2017/12/05)
The present invention provides oxaborole ester compounds and compositions thereof which are useful to treat diseases associated with parasites, such as Chagas Disease and African Animal Trypanosomosis.
PYRAZOLOPYRIMIDINES AS CYCLIN-DEPENDENT KINASE INHIBITORS
-
Page 94, (2008/06/13)
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
